Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1/Th2-independent pathway

Genes and Immunity

Volumn 5, Issue 2, 2004, Pages 93-100

  Elso, C M ^a   Roberts, L J ^a   Smyth, G K ^a   Thomson, R J ^a   Baldwin, T M ^a   Foote, S J ^a   Handman, E ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Immune response genes; Interleukin 4; Leishmania major; Quantitative trait; T lymphocyte subsets

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 4; PORPHOBILINOGEN DEAMINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONGENIC STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE SEVERITY; GENE LOCUS; HOST PARASITE INTERACTION; IMMUNE RESPONSE; INFECTION RESISTANCE; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TH1 CELL; TH2 CELL;

ANIMALS; ANIMALS, CONGENIC; CROSSES, GENETIC; DISEASE MODELS, ANIMAL; DNA PRIMERS; FLUORESCENCE; GENOTYPE; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LINKAGE (GENETICS); MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHENOTYPE; SPECIES SPECIFICITY; TH1 CELLS; TH2 CELLS;

ANIMALIA; LEISHMANIA MAJOR;

EID: 3242808940     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364042     Document Type: Article

References (39)

1. Handman E, Sjölander A, Ilg T et al. Host-parasite interactions in leishmaniasis. Immunologist 2000: 8: 42-44.
2. Walton BC, Valverde L. Racial differences in espundia. Ann Trop Med Parasitol 1979; 73: 23-29.
3. Greenblatt CL. The present and future of vaccination for cutaneous leishmaniasis. Prog Clin Biol Res 1980; 47: 259-285.
4. Doffinger R, Dupuis S, Picard C et al. Inherited disorders of IL-12-and IFN-gamma-mediated immunity: a molecular genetics update. Mol Immunol 2001; 38: 903-909.
5. Goswami T, Bhattacharjee A, Babal P et al. Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem J 2001; 354: 511-519.
6. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
7. Mock B, Blackwell J, Hilgers J, Potter M, Nacy C. Genetic control of Leishmania major infection in congenic, recombinant inbred and F2 populations of mice. Eur J Immunogen 1993; 20: 335-348.
8. Blackwell JM. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 1996; 112: S67-S74.
9. Beebe AM, Mauze S, Schork NJ, Coffman RL. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice. Immunity 1997; 6: 551-557.
10. Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med 1997; 185: 1-6.
11. Roberts LJ, Baldwin TM, Speed TP, Handman E, Foote SJ. Chromosomes X, 9, and the H2 locus interact epistatically to control Leishmania major infection. Eur J Immunol 1999; 29: 3047-3050.
12. Lipoldova M, Svobodova M, Krulova M et al. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes. Genes Immun 2000; 1: 200-206.
13. Locksley RM, Heinzel FP, Sadick MD, Holaday BJ, Gardner KJ. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann Inst Pasteur Immunol 1987; 138: 744-749.
14. Solbach W, Laskay T. The host response to Leishmania infection. Adv Immunol 2000; 74: 275-317.
15. Biedermann T, Zimmermann S, Himmelrich H et al. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat Immunol 2001; 2: 1054-1060.
16. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002; 2: 845-858.
17. Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Infect Dis 1999; 180: 150-155.
18. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T cells. Nature 1996; 383: 787-793.
19. Launois P, Gumy A, Himmelrich H et al. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12- or IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions. J Immunol 2002; 168: 4628-4635.
20. Kropf P, Etges R, Schopf L et al. Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur J Immunol 1999; 29: 3621-3628.
21. Markel P, Shu P, Ebeling C et al. Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nat Genet 1997; 17: 280-284.
22. Wakeland E, Morel L, Achey K, Yui M, Longmate J. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol Today 1997; 18: 472-477.
23. Weil MM, Brown BW, Serachitopol DM. Genotype selection to rapidly breed congenic strains. Genetics 1997; 146: 1061-1069.
24. Roberts M, Mock BA, Blackwell JM. Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogen 1993; 20: 349-362.
25. Wittwer CT, Herrmann MG, Moss AA Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997; 22: 130-131 134-138.
26. Hein J, Schellenberg U, Bein G, Hackstein H. Quantification of murine IFN-gamma mRNA and protein expression: impact of real-time kinetic RT-PCR using SYBR green I dye. Scand J Immunol 2001; 54: 285-291.
27. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169: 59-72.
28. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R b2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997; 185: 817-824.
29. Himmelrich H, Parra-Lopez C, Tacchini-Cottier F, Louis JA, Launois P. The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor B2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12. J Immunol 1998; 161: 6156-6163.
30. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2356.
31. Chatelain R, Mauze S, Coffman RL. Experimental Leishmania major infection in mice: role of IL-10. Parasite Immunol 1999; 21: 211-218.
32. Powrie F, Menon S, Coffman RL. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur J Immunol 1993; 23: 3043-3049.
33. Belkaid Y, Hoffman KF, Mendez S et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001; 194: 1497-1506.
34. Morris L, Troutt A, McLeod KS et al. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun 1993; 61: 3459-3465.
35. Handman E, Hocking RE, Mitchell GF, Spithill TW. Isolation and characterization of infective and non-infective clones of Leishmania tropica. Mol Biochem Parasitol 1983; 7: 111-126.
36. Mitchell GF, Curtis JM, Handman E, McKenzie IFC. Cutaneous leishmaniasis in mice: disease patterns in reconstituted nude mice of several genotypes infected with Leishmania tropica. Aust J Exp Biol Med Sci 1980; 58: 521-532.
37. Shaffer JP. Multiple hypothesis testing. Annu Rev Psychol 1995; 46: 561-576.
38. Chretien S, Dubart A, Beaupain D et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 1988; 85: 6-10.
39. Simpson DA, Feeney S, Boyle C, Stitt AW. Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR. Mol Vis 2000; 6: 178-183.